MAIA Biotechnology Inc. (MAIA)

Journal Article Confirms MOA In An Additional Tumor Type


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
February 8, 2024
Report ID: 26503
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


MAIA Biotechnology Inc.
MAIA Biotechnology Inc.
Healthcare
Biotechnology
Ticker
MAIA
Current Price
$3.64 6.12%
Market Cap
$79.5M
Price Target
Refer to Report
Volume
65.8K
52wk Range
$0.82 - $5.99
Related Research Reports
6/5/2024

THIO-101 Data Update Shows Continued Efficacy
THIO-101 Data Update Shows Continued Efficacy (MAIA)
3/7/2024

New THIO-101 Update Shows Consistent Overall Response Rate
New THIO-101 Update Shows Consistent Overall Response Rate (MAIA)
2/23/2024

THIO-101 Patient Enrollment Completed Ahead Of Schedule
THIO-101 Patient Enrollment Completed Ahead Of Schedule (MAIA)
2/8/2024

Journal Article Confirms MOA In An Additional Tumor Type
Journal Article Confirms MOA In An Additional Tumor Type (MAIA)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy